Page last updated: 2024-09-03

y 27632 and vatalanib

y 27632 has been researched along with vatalanib in 1 studies

Compound Research Comparison

Studies
(y 27632)
Trials
(y 27632)
Recent Studies (post-2010)
(y 27632)
Studies
(vatalanib)
Trials
(vatalanib)
Recent Studies (post-2010) (vatalanib)
1,92438912764298

Protein Interaction Comparison

ProteinTaxonomyy 27632 (IC50)vatalanib (IC50)
Bile salt export pumpHomo sapiens (human)10
Epidermal growth factor receptorHomo sapiens (human)0.4577
Platelet-derived growth factor receptor betaHomo sapiens (human)0.2013
Mast/stem cell growth factor receptor KitHomo sapiens (human)0.73
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.1192
Vascular endothelial growth factor receptor 3Homo sapiens (human)0.1475
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.378
Vascular endothelial growth factor receptor 2Danio rerio (zebrafish)0.49

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1

Other Studies

1 other study(ies) available for y 27632 and vatalanib

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007